Stocks

The table gives an overview of all stocks, alphabetically sorted.
 K-Fast Holding B KFASTB 0.00 0.00   
 K2A Knaust & Andersson Fastigh K2AB Jan 27, 2020 168.20 -0.47   
 K2A Knaust & Andersson Fastigh K2APREF Jan 27, 2020 353.00 -0.28   
 KABE Group B KABEB Jan 27, 2020 149.50 -0.66   
 Kakel Max KAKEL Jan 27, 2020 11.60 -2.52   
 Kallebäck Property Invest KAPIAB Jan 27, 2020 189.00 -1.82   
 Kambi Group KAMBI Jan 27, 2020 126.50 -2.32   
 Kancera KAN Jan 27, 2020 0.61 +2.01   
 Karessa Pharma Holding KARE Jan 27, 2020 2.82 +2.17   
 Karnov Group KAR Jan 27, 2020 52.00 -0.95   
 Karo Pharma KARO Jan 27, 2020 42.88 -1.74   
 Karolinska Development B KDEV Jan 27, 2020 3.45 -0.58   
 Kentima Holding B KENH Jan 27, 2020 1.22 -3.19   
 Kid KIDO Jan 27, 2020 61.60 0.00   
 Kindred Group SDB KINDSDB Jan 27, 2020 48.20 -1.13   
 Kinnevik A KINVA Jan 27, 2020 234.00 -1.27   
 Kinnevik B KINVB Jan 27, 2020 229.80 -2.05   
 Kitron KITO Jan 27, 2020 10.34 0.00   
 Klaria Pharma Holding KLAR Jan 27, 2020 5.02 +1.62   
 Klövern A KLOVA Jan 27, 2020 23.40 -2.09   
 Klövern B KLOVB Jan 27, 2020 23.64 -0.84   
 Klövern Pref KLOVPREF Jan 27, 2020 376.00 -0.53   
 Knowit KNOW Jan 27, 2020 197.80 -2.80   
 Kollect on Demand Holding KOLL Jan 27, 2020 8.05 0.00   
 Komplett Bank KOMPO Jan 27, 2020 12.42 0.00   
 Kongsberg Automotive ASA KOAO Jan 27, 2020 5.05 0.00   
 Kongsberg Gruppen KOGO Jan 27, 2020 143.00 -1.17   
 Kontigo Care KONT Jan 27, 2020 4.45 -2.84   
 Kopparbergs B KOBRB Jan 27, 2020 169.60 -1.17   
 Kopy Goldfields KOPY Jan 27, 2020 1.09 -2.69   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK